about
Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle studySimultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis.Ocular findings in patients with systemic sclerosis.Abnormal B lymphocyte activation and function in systemic sclerosis.Double heterozygous mice for Klf5 and Fli1 genes: a new animal model of systemic sclerosis recapitulating its three cardinal pathological features.Recent advances in animal models of systemic sclerosis.B lymphocytes in systemic sclerosis: Abnormalities and therapeutic targets.Challenges and opportunities in treating inflammation associated with pulmonary hypertension.Rituximab for refractory digital infarcts and ulcers in systemic sclerosis.Association of immunological cell profiles with specific clinical phenotypes of scleroderma disease.B-cell depletion therapy in systemic sclerosis: experimental rationale and update on clinical evidence.Autoantibody-mediated regulation of B cell responses by functional anti-CD22 autoantibodies in patients with systemic sclerosis.Rituximab treatment in patients with systemic sclerosis and interstitial lung disease.Successful treatment of steroid and cyclophosphamide-resistant diffuse scleroderma-associated interstitial lung disease with rituximab.Relation between elevated high-sensitivity C-reactive protein and anti-mitochondria antibody in patients with systemic sclerosis.Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease
P2860
Q33588875-D7915485-CBA3-4A0B-B316-131931B8AD50Q34721223-4FB846E8-5153-4D12-ADD3-CCE31B9DC673Q34768694-D64D35C5-3392-4223-887B-AEE5F23FEBFFQ38352418-8CE8A931-5B1F-4B07-982A-3000B14AF012Q38489606-75A1F1FB-70F7-4821-A701-F32219EE8C5BQ38701983-CF1BC0BD-5597-4E9C-A1D0-41CE6D715682Q38701988-716D13B2-19BA-4E36-8263-38BA21CD9E7CQ38812727-BCC4C4C7-72B4-4A10-865A-2C4460A0B257Q40183904-B82A4454-C38B-403D-829F-C3A6B0F4BFEBQ41223874-85825CE8-FA6D-4C6B-A7FD-EB26C39086F6Q42855117-5731D0CA-4264-403B-85D1-2745923D8AB4Q43240473-6B25B64C-3DF8-40E9-AD84-C2D67FA4565AQ47107441-31DD7179-F87B-4941-80D2-0E9814D3F6E6Q51593209-C118BD50-2777-4AD2-B3D3-B791366F12B2Q51715317-CB79DC75-FACE-49A9-BBC2-93F1357FE389Q57753247-ACF1D7A8-4F96-4B2D-BDB3-99DA934772B4
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
B lymphocytes and systemic sclerosis.
@ast
B lymphocytes and systemic sclerosis.
@en
type
label
B lymphocytes and systemic sclerosis.
@ast
B lymphocytes and systemic sclerosis.
@en
prefLabel
B lymphocytes and systemic sclerosis.
@ast
B lymphocytes and systemic sclerosis.
@en
P1476
B lymphocytes and systemic sclerosis.
@en
P2093
Manabu Fujimoto
Shinichi Sato
P304
P356
10.1097/01.BOR.0000179945.73518.28
P577
2005-11-01T00:00:00Z